Camber Launches Spironolactone Tablets

Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Spironolactone Tablets [spir-ON-oh-LAK-tone].

Spironolactone Tablets are indicated for treatment of Heart Failure, Hypertension, Edema Associated with Hepatic Cirrhosis or Nephrotic Syndrome, and Primary Hyperaldosteronism.

For complete indications, click here.

Spironolactone Tablets are available in:

Strength Size
25 mg 100, 500, and 1,000 ct
50 mg 100 and 500 ct
100 mg 100 and 500 ct

Learn More about Spironolactone Tablets